Search Ontology:
ChEBI
brivaracetam
- Term ID
- CHEBI:133013
- Synonyms
-
- (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
- 2-(2-Oxo-4-propylpyrrolidin-1-yl)butanamide
- brivaracetam
- Briviact
- UCB 34714
- UCB34714
- Definition
- A non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy.
- References
-
- CAS:357336-20-0
- Drug_Central:5068
- KEGG:D08879
- PMID:26515103
- PMID:26664121
- PMID:26666500
- PMID:26719676
- PMID:26740317
- PMID:26760311
- PMID:26891946
- PMID:26899665
- PMID:26920914
- PMID:26944275
- PMID:27002062
- PMID:27146213
- PMID:27192732
- PMID:27217762
- PMID:27221208
- PMID:27236448
- PMID:27252986
- PMID:27265725
- PMID:27274002
- PMID:27335114
- PMID:27346728
- PMID:27389600
- PMID:27403785
- PMID:27450143
- PMID:27503181
- Reaxys:9629290
- Wikipedia:Brivaracetam
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- has_role
-
Phenotype
Phenotype resulting from brivaracetam
Phenotype where environments contain brivaracetam
Phenotype modified by environments containing brivaracetam
Human Disease Model